A U.S. Circuit Court of Appeals panel ruled 2-1 that the 2018 law does not violate drugmakers’ constitutional rights
Oregon Drug Pricing Transparency Law Remains In Effect

A U.S. Circuit Court of Appeals panel ruled 2-1 that the 2018 law does not violate drugmakers’ constitutional rights